James Sapirstein, Chairman and CEO at First Wave BioPharma, Inc. (FWBI), sold 174 shares at $4.23 ($736) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Open-market sale of $736 FWBI by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FWBI | SELL | 2024-01-17 | $697 | — | Filing → |
| FWBI | SELL | 2023-10-06 | $802 | — | Filing → |
| FWBI | SELL | 2023-07-05 | $5K | — | Filing → |